Skip to main content

Table 3 Yearly expected costs per patient by treatment and by time period, BAT + GDT vs. GDT alone, 2018 US Dollars (HF hospitalization rate relative reduction = 25%)

From: Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States

Time period (a)

BAT + GDT

GDT Alone

Difference

1 Year

$53,141

$28,093

$25,047

2 Years

$14,184

$21,049

$(6,865)

3 Years

$9,541

$31,602

($22,061)

  1. (a) time period is marked by the implantation of the BAT device; 6-month data pertains to the BeAT-HF clinical trial, whereas years 1, 2 and 3 are based on extrapolations (see text)